SLP News and Press, Simulations Plus Inc. From 04/04/24

Simulations Plus, Inc. (NASDAQ: SLP) is one of today's top gainers. The company's shares have moved 22.75% on the day to $47.21. Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial inte...

Predicting DILI risk supports informed decision-making regarding drug evaluations and approvals Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today anno...

2024-04-03 23:15:17 ET Simulations Plus, Inc. (SLP) Q2 2023 Results Earnings Conference Call April 4, 2024, 05:00 PM ET Company Participants Lisa Fortuna - Investor Relations, Financial Profiles Shawn O'Connor - Chief Executive Officer Will Frederick - Chief Fina...

2024-04-03 17:24:42 ET Gainers: Signature Bank ( OTC:SBNY ) +10% . MacroGenics ( MGNX ) +9% . Simulations Plus ( SLP ) +7% . Annexon ( ANNX ) +6% . 2seventy  ( TSVT ) +5% . Losers: Cadiz ( CDZIP ) -11% . ...

Total revenue of $18.3 million and diluted earnings per share (EPS) of $0.20 Maintains full-year revenue guidance of $66 to $69 million (+10-15%) and EPS guidance of $0.66 to $0.68 Simulations Plus, Inc. (NASDAQ: SLP) (“Simulations Plus”), a leading provider of mod...

Sportsman's Warehouse Holdings Inc. (SPWH) is expected to report $-0.3 for Q4 2024 IDW Media Holdings, Inc. (IDWM) is expected to report for quarter end 2024-01-31 Klepierre (KLPEF) is expected to report for Q4 2023 Steakholder Foods Ltd. (STKH) is expected to report for Q4 2023 R...

2024-04-02 17:35:30 ET More on Simulations Plus Simulations Plus: Questionable Whether It Will Benefit Or Be Hurt By Generative AI Simulations Plus, Inc. (SLP) Q1 2024 Earnings Call Transcript Simulations Plus, Inc. 2024 Q1 - Results - Earnings Call Presentation ...

Conference call to be on Wednesday, April 3, 2024, at 5 p.m. EDT Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), announced today that it will report second quarter fiscal 2024 financial results after the market close on Wednesday, April 3, 2024. Management...

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that Shawn O’Connor, chief executive officer, will be hosting a fireside chat at the KeyBanc ...

2024-03-09 04:50:41 ET Summary Health Catalyst reported strong Q4 results, meeting guidance and showing growth in technology and professional services revenue. The drop in HCAT's share price presents a buying opportunity, as the company's growth initiatives, such as its TEMS offer...